ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
1 Jul 2020	Submitted	Original manuscript
2 Jul 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
4 Jul 2020	Editorially accepted
31 Jul 2020	Article published	10.1186/s13063-020-04584-9

Back to article page